1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name![]() |
Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Eculizumab | Soliris | Humanized monoclonal antibody | 2009/06/29 |
Edaravone | Radicava | Treatment for amyotrophic lateral sclerosis | 2019/10/29 |
Edoxaban | Lixiana | Anticoagulant | 2017/01 |
Elagolix | Orilissa | Gonadotropin releasing hormone receptor antagonist | 2018/10/31 |
Elbasvir + grazoprevir | Zepatier | Antiviral agent | 2016/02/02 |
Elexacaftor + tezacaftor + ivacaftor | Trikafta | Cystic fibrosis transmembrane conductance regulator correctors | 2021/06/22 |
Eltrombopag | Revolade | Thrombopoietin receptor antagonist | 2011/0404 |
Eluxadoline | Viberzi | Miscellaneous GI drug | 2017/05 |
Eluxadoline | Viberzi | Miscellaneous GI drugs | 2017/04/24 |
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide | Genvoya | Antiretroviral agents | 2016/02/03 |
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate | Stribild | Antiretroviral agent | 2012/12/20 |
Empagliflozin | Jardiance | Sodium-glucose contransporter 2 (SGLT2) inhibitor | 2015/08/11 |
Empagliflozin + linagliptin | Glyxambi | Antidiabetic agent | 2016/12/15 |
Empagliflozin + metformin | Synjardy | Oral blood glucose lowering agents | 2017/09/18 |
Emtricitabine + tenofovir | Descovy | Antiretroviral agent | 2016/06/03 |
Enasidenib | IDHIFA | Antineoplastic agent / IDH2 Inhibitor | 2019/02/27 |
Entrectinib | Rozlytrek | Antineoplastic agent | |
Enzalutamide | Xtandi | Antineoplastic agent | 2013/06/07 |
Eplerenone | Inspra | Aldosterone antagonist | 2009/02/26 |
Eptinezumab | Vyepti | Prevention of migraine; calcitonin gene-related peptide binding antibody | 2021/01/11 |
Erdafitinib | Balversa | Protein kinase inhibitor | 2019/12/09 |
Erenumab | Aimovig | Anti-calcitonin gene-related peptide receptor | 2018/08/01 |
Eribulin | Halaven | Antineoplastic agent | 2012/03/10 |
Ertugliflozin | Steglatro | Sodium-glucose co-transporter 2 (SGLT2) inhibitor | 2018/05/23 |
Ertugliflozin + metformin | Segluromet | Oral blood glucose lowering agents | 2018/05/30 |
Ertugliflozin + sitagliptin | Steglujan | Oral blood glucose lowering agents | 2018/05/22 |
Escitalopram | Cipralex MELTZ | Selective serotonin reuptake inhibitor | 2013/01/15 |
Esketamine | Spravato | Antidepressant | 2020/05/20 |
Esomeprazole + Naproxen | Vimovo | NSAID + PPI | 2011/01/14 |
Estradiol | Vagifem | Hormone replacement therapy | 2011/12/31 |
Estradiol gel | Divigel | Topical estrogen | 2012/10 |
Estropipate | Ogen | ||
Eszopiclone | Lunesta | Hypnotic | 2020/10/20 |
Ethinyl estradiol + levonorgestrel | Seasonique | Oral contraceptive | 2011/04/15 |
Ethinyl estradiol + norethindrone | Lolo | Oral contraceptive | 2014/07/03 |
Ethinyl estradiol + norgestrel | Ovral | Oral contraceptive |